(a) The practitioner may issue a prescription for a Schedule II, III, IV or V controlled substance electronically if an electronic prescription application is used that has been certified by a third party auditor to ensure that the electronic prescription application records, stores, and transmits the prescription accurately and consistently and that individual practitioner has obtained a two-factor authentication credential for signing.
(b) The electronic prescription application must transmit the electronic prescription as soon as possible after signature by the practitioner and the contents of the prescription must not be altered during transmission between the practitioner and pharmacy.
(c) The pharmacy receiving the electronic prescription must determine that third-party certification has found that the pharmacy application accurately and consistently imports, stores and displays the information required for the prescription including the number of refills and the practitioner's digital signature.
(d) An electronic prescription shall only be transmitted to the pharmacy of the patient's choice.
(e) The pharmacist is responsible for assuring the validity of the electronically transmitted prescription.
(f) A pharmacist or pharmacy shall not enter into any agreement to provide or receive a computer modem, personal digital assistant, facsimile machine, or any other electronic device which would adversely affect a patient's freedom to select the pharmacy of the patient's choice.
(g) A pharmacist or pharmacy shall not provide a computer or computer modem, personal digital assistant, facsimile machine or any other electronic device to a prescriber or health care facility for the purpose of providing an incentive to refer a patient to a particular pharmacy.
059-6 Wyo. Code R. § 6-12
Amended, Eff. 5/16/2017.
Amended, Eff. 12/11/2018.